Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

PHASE2CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1998

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Sevirumab

DRUG

Foscarnet sodium

DRUG

Ganciclovir

Trial Locations (20)

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

14642

Univ. of Rochester ACTG CRS, Rochester

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

35294

Alabama Therapeutics CRS, Birmingham

44106

Case CRS, Cleveland

60612

Cook County Hosp. CORE Ctr., Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

80262

University of Colorado Hospital CRS, Aurora

96816

Queens Med. Ctr., Honolulu

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

331361013

Univ. of Miami AIDS CRS, Miami

452670405

Univ. of Cincinnati CRS, Cincinnati

462025250

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

900331079

USC CRS, Los Angeles

943055107

Stanford CRS, Stanford

951282699

Santa Clara Valley Med. Ctr., San Jose

02114

Massachusetts General Hospital ACTG CRS, Boston

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Unknown

Washington U CRS, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Facet Biotech

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH